{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T17:55:52Z","timestamp":1791741352710,"version":"4.3.4"},"reference-count":87,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH NIAID","award":["U54 AI065357"],"award-info":[{"award-number":["U54 AI065357"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.vaccine.2011.05.009","type":"journal-article","created":{"date-parts":[[2011,5,23]],"date-time":"2011-05-23T21:45:08Z","timestamp":1306187108000},"page":"5304-5312","source":"Crossref","is-referenced-by-count":36,"title":["Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity"],"prefix":"10.1016","volume":"29","author":[{"given":"Angela","family":"Henderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Propst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Kedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Dow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"December (11)","key":"10.1016\/j.vaccine.2011.05.009_bib0005","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.4049\/jimmunol.0901466","article-title":"What role does the route of immunization play in the generation of protective immunity against mucosal pathogens?","volume":"183","author":"Belyakov","year":"2009","journal-title":"J Immunol"},{"issue":"March (12)","key":"10.1016\/j.vaccine.2011.05.009_bib0440","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/j.vaccine.2009.12.084","article-title":"Vaccine adjuvants: a priority for vaccine research","volume":"28","author":"Harandi","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.05.009_bib0015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev.micro.51.1.311","article-title":"Interaction of antigens and antibodies at mucosal surfaces","volume":"51","author":"Lamm","year":"1997","journal-title":"Annu Rev Microbiol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.05.009_bib0020","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"April (4 Suppl.)","key":"10.1016\/j.vaccine.2011.05.009_bib0025","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat Med"},{"issue":"February (7)","key":"10.1016\/j.vaccine.2011.05.009_bib0030","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMoa065368","article-title":"Live attenuated versus inactivated influenza vaccine in infants and young children","volume":"356","author":"Belshe","year":"2007","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.vaccine.2011.05.009_bib0035","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1128\/IAI.67.7.3680-3685.1999","article-title":"Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria","volume":"67","author":"Viret","year":"1999","journal-title":"Infect Immun"},{"issue":"May\u2013June (3)","key":"10.1016\/j.vaccine.2011.05.009_bib0040","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1051\/vetres:2006014","article-title":"Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa","volume":"37","author":"Cox","year":"2006","journal-title":"Vet Res"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2011.05.009_bib0045","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0952-7915(02)00384-9","article-title":"Recent advances in mucosal vaccines and adjuvants","volume":"14","author":"Eriksson","year":"2002","journal-title":"Curr Opin Immunol"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2011.05.009_bib0050","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/1567201043334588","article-title":"Mucosal immunisation: adjuvants and delivery systems","volume":"1","author":"Moyle","year":"2004","journal-title":"Curr Drug Deliv"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2011.05.009_bib0055","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1586\/14760584.6.3.419","article-title":"Intranasal vaccines for protection against respiratory and systemic bacterial infections","volume":"6","author":"Oliveira","year":"2007","journal-title":"Expert Rev Vaccines"},{"issue":"March (15)","key":"10.1016\/j.vaccine.2011.05.009_bib0060","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.vaccine.2004.11.010","article-title":"Mucosal adjuvants","volume":"23","author":"Freytag","year":"2005","journal-title":"Vaccine"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2011.05.009_bib0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jcv.2004.03.001","article-title":"The potential of immunostimulatory CpG DNA for inducing immunity against genital herpes: opportunities and challenges","volume":"30","author":"Harandi","year":"2004","journal-title":"J Clin Virol"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2011.05.009_bib0070","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1586\/14760584.6.2.193","article-title":"Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic","volume":"6","author":"Hasegawa","year":"2007","journal-title":"Expert Rev Vaccines"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2011.05.009_bib0075","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.imlet.2004.11.009","article-title":"Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA","volume":"97","author":"Holmgren","year":"2005","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2011.05.009_bib0080","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.2741\/1452","article-title":"Current vaccine adjuvants: an overview of a diverse class","volume":"September (9)","author":"Kensil","year":"2004","journal-title":"Front Biosci"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.05.009_bib0085","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.addr.2008.12.012","article-title":"CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases","volume":"61","author":"Klinman","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"issue":"June (27)","key":"10.1016\/j.vaccine.2011.05.009_bib0090","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1016\/S0264-410X(01)00088-3","article-title":"Mucosal immunization of mice using CpG DNA and\/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants","volume":"19","author":"McCluskie","year":"2001","journal-title":"Vaccine"},{"issue":"March (17\u201319)","key":"10.1016\/j.vaccine.2011.05.009_bib0095","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/S0264-410X(00)00496-5","article-title":"The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants","volume":"19","author":"McCluskie","year":"2001","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2011.05.009_bib0100","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2174\/1381612053381846","article-title":"Mucosal adjuvants","volume":"11","author":"Stevceva","year":"2005","journal-title":"Curr Pharm Des"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2011.05.009_bib0105","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.mib.2003.09.007","article-title":"Treatment of infectious diseases with immunostimulatory oligodeoxynucleotides containing CpG motifs","volume":"6","author":"Dittmer","year":"2003","journal-title":"Curr Opin Microbiol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.05.009_bib0110","first-page":"686","article-title":"CpG oligodeoxynucleotides for immune stimulation in cancer immunotherapy","volume":"4","author":"Jahrsdorfer","year":"2003","journal-title":"Curr Opin Investig Drugs"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.05.009_bib0115","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nrd2059","article-title":"Therapeutic potential of toll-like receptor 9 activation","volume":"5","author":"Krieg","year":"2006","journal-title":"Nat Rev Drug Discov"},{"issue":"June (19\u201320)","key":"10.1016\/j.vaccine.2011.05.009_bib0120","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/S0264-410X(02)00155-X","article-title":"A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants","volume":"20","author":"Fujihashi","year":"2002","journal-title":"Vaccine"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.05.009_bib0125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nm987","article-title":"Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration","volume":"10","author":"Heikenwalder","year":"2004","journal-title":"Nat Med"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.05.009_bib0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nri1329","article-title":"Immunotherapeutic uses of CpG oligodeoxynucleotides","volume":"4","author":"Klinman","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2011.05.009_bib0135","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.4049\/jimmunol.165.9.4778","article-title":"Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues","volume":"165","author":"van Ginkel","year":"2000","journal-title":"J Immunol"},{"issue":"March\u2013April (2)","key":"10.1016\/j.vaccine.2011.05.009_bib0140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3201\/eid0602.000204","article-title":"Vaccines for mucosal immunity to combat emerging infectious diseases","volume":"6","author":"van Ginkel","year":"2000","journal-title":"Emerg Infect Dis"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2011.05.009_bib0145","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ymeth.2009.03.027","article-title":"Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in mice","volume":"49","author":"Acevedo","year":"2009","journal-title":"Methods"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2011.05.009_bib0150","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2249.2006.03114.x","article-title":"Effects of alveolar macrophage depletion on liposomal vaccine protection against respiratory syncytial virus (RSV)","volume":"145","author":"Benoit","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2011.05.009_bib0155","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2172-9-38","article-title":"Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes","volume":"9","author":"Rosada","year":"2008","journal-title":"BMC Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.05.009_bib0160","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4049\/jimmunol.170.1.495","article-title":"HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses","volume":"170","author":"Sakaue","year":"2003","journal-title":"J Immunol"},{"issue":"October (3\u20134)","key":"10.1016\/j.vaccine.2011.05.009_bib0165","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.vetimm.2009.04.009","article-title":"Effect of lipopolysaccharide on intranasal administration of liposomal Newcastle disease virus vaccine to SPF chickens","volume":"131","author":"Tseng","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"issue":"December (Suppl. 1)","key":"10.1016\/j.vaccine.2011.05.009_bib0170","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/j.jcv.2004.09.013","article-title":"Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses","volume":"31","author":"Wang","year":"2004","journal-title":"J Clin Virol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.05.009_bib0445","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1517\/17425247.2010.488687","article-title":"Liposomes as delivery systems for nasal vaccination: strategies and outcomes","volume":"7","author":"Heurtault","year":"2010","journal-title":"Expert Opin Drug Deliv"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2011.05.009_bib0180","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1023\/A:1020151025412","article-title":"Liposomal delivery of CTL epitopes to dendritic cells","volume":"22","author":"Chikh","year":"2002","journal-title":"Biosci Rep"},{"issue":"February (9\u201310)","key":"10.1016\/j.vaccine.2011.05.009_bib0185","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0264-410X(02)00536-4","article-title":"Liposomal delivery of antigen to human dendritic cells","volume":"21","author":"Copland","year":"2003","journal-title":"Vaccine"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.05.009_bib0190","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat Rev Drug Discov"},{"issue":"April (21)","key":"10.1016\/j.vaccine.2011.05.009_bib0195","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/S0264-410X(00)00019-0","article-title":"Intranasal immunization with liposome-formulated Yersinia pestis vaccine enhances mucosal immune responses","volume":"18","author":"Baca-Estrada","year":"2000","journal-title":"Vaccine"},{"issue":"April (18)","key":"10.1016\/j.vaccine.2011.05.009_bib0200","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.vaccine.2008.02.058","article-title":"Surface modified liposomes for nasal delivery of DNA vaccine","volume":"26","author":"Khatri","year":"2008","journal-title":"Vaccine"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2011.05.009_bib0205","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.4049\/jimmunol.176.12.7335","article-title":"Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes","volume":"176","author":"Zaks","year":"2006","journal-title":"J Immunol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.05.009_bib0210","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrmicro1681","article-title":"The perfect mix: recent progress in adjuvant research","volume":"5","author":"Guy","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.05.009_bib0215","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1586\/erv.10.154","article-title":"Combination adjuvants: the next generation of adjuvants?","volume":"10","author":"Mutwiri","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.05.009_bib0220","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1128\/CVI.00370-08","article-title":"Potent adjuvant activity of cationic liposome\u2013DNA complexes for genital herpes vaccines","volume":"16","author":"Bernstein","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2011.05.009_bib0225","article-title":"The adjuvant CLDC increases protection of a herpes simplex type 2 glycoprotein D vaccine in guinea pigs","author":"Bernstein","year":"2009","journal-title":"Vaccine"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2011.05.009_bib0230","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.biologicals.2009.02.019","article-title":"A novel vaccine adjuvant for recombinant flu antigens","volume":"37","author":"Chang","year":"2009","journal-title":"Biologicals"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.05.009_bib0235","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/jmv.21566","article-title":"Rapid immunity to vaccination with woodchuck hepatitis virus surface antigen using cationic liposome\u2013DNA complexes as adjuvant","volume":"81","author":"Cote","year":"2009","journal-title":"J Med Virol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.05.009_bib0240","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4161\/hv.5.3.6589","article-title":"Enhanced in vivo immunogenicity of SIV vaccine candidates with cationic liposome\u2013DNA complexes in a rhesus macaque pilot study","volume":"5","author":"Fairman","year":"2009","journal-title":"Hum Vaccin"},{"issue":"June (29)","key":"10.1016\/j.vaccine.2011.05.009_bib0245","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1016\/j.vaccine.2009.04.054","article-title":"Cationic lipid\/DNA complexes (JVRS-100) combined with influenza vaccine (Fluzone) increases antibody response, cellular immunity, and antigenically drifted protection","volume":"27","author":"Lay","year":"2009","journal-title":"Vaccine"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.05.009_bib0250","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1128\/IAI.01384-08","article-title":"Protection from pneumonic infection with Burkholderia species by inhalational immunotherapy","volume":"77","author":"Goodyear","year":"2009","journal-title":"Infect Immun"},{"issue":"July (33)","key":"10.1016\/j.vaccine.2011.05.009_bib0255","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/j.vaccine.2009.05.041","article-title":"Mucosal immunotherapy for protection from pneumonic infection with Francisella tularensis","volume":"27","author":"Troyer","year":"2009","journal-title":"Vaccine"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.05.009_bib0260","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nbt0797-647","article-title":"Improved DNA: liposome complexes for increased systemic delivery and gene expression","volume":"15","author":"Templeton","year":"1997","journal-title":"Nat Biotechnol"},{"issue":"December (1\u20132)","key":"10.1016\/j.vaccine.2011.05.009_bib0265","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-1759(98)00170-7","article-title":"A statistically defined endpoint titer determination method for immunoassays","volume":"221","author":"Frey","year":"1998","journal-title":"J Immunol Methods"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.05.009_bib0270","first-page":"661","article-title":"Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles","volume":"81","author":"Maloy","year":"1994","journal-title":"Immunology"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2011.05.009_bib0275","doi-asserted-by":"crossref","first-page":"6792","DOI":"10.4049\/jimmunol.175.10.6792","article-title":"Francisella tularensis induces aberrant activation of pulmonary dendritic cells","volume":"175","author":"Bosio","year":"2005","journal-title":"J Immunol"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2011.05.009_bib0280","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1165\/ajrcmb.27.1.4563","article-title":"Lymphocyte activation in the lungs of SP-D null mice","volume":"27","author":"Fisher","year":"2002","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2011.05.009_bib0285","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1084\/jem.20031591","article-title":"Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN","volume":"199","author":"Ahonen","year":"2004","journal-title":"J Exp Med"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2011.05.009_bib0450","first-page":"1445","article-title":"Critical protective role for MCP-1 in pneumonic Burkholderia mallei infection","volume":"184","author":"Goodyear","year":"2011","journal-title":"J Immunol"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2011.05.009_bib0295","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.4049\/jimmunol.160.8.4090","article-title":"Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice","volume":"160","author":"Lambrecht","year":"1998","journal-title":"J Immunol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.05.009_bib0300","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1128\/IAI.68.7.3888-3893.2000","article-title":"The CXC chemokines gamma interferon (IFN-gamma)-inducible protein 10 and monokine induced by IFN-gamma are released during severe melioidosis","volume":"68","author":"Lauw","year":"2000","journal-title":"Infect Immun"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2011.05.009_bib0305","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.4049\/jimmunol.160.9.4580","article-title":"Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: cationic lipid complexes","volume":"160","author":"Freimark","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.05.009_bib0310","doi-asserted-by":"crossref","unstructured":"Propst KL, Troyer RM, Kellihan LM, Schweizer HP, Dow SW. Immunotherapy markedly increases the effectiveness of antimicrobial therapy for treatment of Burkholderia pseudomallei infection. Antimicrob Agents Chemother (2010 February 22).","DOI":"10.1128\/AAC.01513-09"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.05.009_bib0315","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nri2322","article-title":"The regulation of IgA class switching","volume":"8","author":"Cerutti","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.05.009_bib0320","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nri982","article-title":"Intestinal IgA synthesis: regulation of front-line body defences","volume":"3","author":"Fagarasan","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.05.009_bib0325","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/mi.2007.6","article-title":"The immune geography of IgA induction and function","volume":"1","author":"Macpherson","year":"2008","journal-title":"Mucosal Immunol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.05.009_bib0330","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1128\/IAI.64.5.1516-1525.1996","article-title":"Oral immunization of interleukin-4 (IL-4) knockout mice with a recombinant Salmonella strain or cholera toxin reveals that CD4+ Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses","volume":"64","author":"Okahashi","year":"1996","journal-title":"Infect Immun"},{"issue":"September (37)","key":"10.1016\/j.vaccine.2011.05.009_bib0335","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1016\/j.vaccine.2008.06.091","article-title":"A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity","volume":"26","author":"Fukuiwa","year":"2008","journal-title":"Vaccine"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.05.009_bib0340","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF02977620","article-title":"Intranasal vaccination with peptides and cholera toxin subunit B as adjuvant to enhance mucosal and systemic immunity to respiratory syncytial virus","volume":"30","author":"Kim","year":"2007","journal-title":"Arch Pharm Res"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2011.05.009_bib0345","doi-asserted-by":"crossref","first-page":"834","DOI":"10.4049\/jimmunol.158.2.834","article-title":"Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo","volume":"158","author":"Porgador","year":"1997","journal-title":"J Immunol"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2011.05.009_bib0350","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.4049\/jimmunol.180.6.4000","article-title":"Suppression of an already established tumor growing through activated mucosal CTLs induced by oral administration of tumor antigen with cholera toxin","volume":"180","author":"Wakabayashi","year":"2008","journal-title":"J Immunol"},{"issue":"February (1\u20133)","key":"10.1016\/j.vaccine.2011.05.009_bib0355","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0168-3659(01)00549-1","article-title":"Targeting to macrophages: role of physicochemical properties of particulate carriers \u2013 liposomes and microspheres \u2013 on the phagocytosis by macrophages","volume":"79","author":"Ahsan","year":"2002","journal-title":"J Control Release"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2011.05.009_bib0360","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijpharm.2005.03.035","article-title":"Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model","volume":"298","author":"Foged","year":"2005","journal-title":"Int J Pharm"},{"issue":"November (3)","key":"10.1016\/j.vaccine.2011.05.009_bib0365","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1006\/bbrc.1997.7749","article-title":"Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins","volume":"240","author":"Nakanishi","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2011.05.009_bib0370","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.4049\/jimmunol.173.10.6143","article-title":"Vesicle size influences the trafficking, processing, and presentation of antigens in lipid vesicles","volume":"173","author":"Brewer","year":"2004","journal-title":"J Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.05.009_bib0375","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1517\/17425247.5.1.11","volume":"5","author":"Dow","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.05.009_bib0380","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1084\/jem.169.6.2133","article-title":"Interleukins and IgA synthesis human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells","volume":"169","author":"Beagley","year":"1989","journal-title":"J Exp Med"},{"issue":"November (5)","key":"10.1016\/j.vaccine.2011.05.009_bib0385","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1172\/JCI117556","article-title":"Airway epithelial cell expression of interleukin-6 in transgenic mice uncoupling of airway inflammation and bronchial hyperreactivity","volume":"94","author":"DiCosmo","year":"1994","journal-title":"J Clin Invest"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2011.05.009_bib0390","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF00916814","article-title":"Regulation of IgA synthesis and immune response by T cells and interleukins","volume":"9","author":"McGhee","year":"1989","journal-title":"J Clin Immunol"},{"issue":"June (8)","key":"10.1016\/j.vaccine.2011.05.009_bib0395","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/0264-410X(95)00231-O","article-title":"Humoral and cellular immune responses in the murine respiratory tract following oral immunization with cholera toxin or Escherichia coli heat-labile enterotoxin","volume":"14","author":"Ruedl","year":"1996","journal-title":"Vaccine"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2011.05.009_bib0400","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.4049\/jimmunol.171.7.3684","article-title":"CD11b+ Peyer's patch dendritic cells secrete IL-6 and induce IgA secretion from naive B cells","volume":"171","author":"Sato","year":"2003","journal-title":"J Immunol"},{"issue":"March (3 Suppl.)","key":"10.1016\/j.vaccine.2011.05.009_bib0405","doi-asserted-by":"crossref","first-page":"131S","DOI":"10.1378\/chest.107.3_Supplement.131S","article-title":"Expression of interleukin-6 by airway epithelial cells effects on airway inflammation and hyperreactivity in transgenic mice","volume":"107","author":"DiCosmo","year":"1995","journal-title":"Chest"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.05.009_bib0410","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1002\/eji.1830271209","article-title":"Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions","volume":"27","author":"Jonuleit","year":"1997","journal-title":"Eur J Immunol"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2011.05.009_bib0415","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1084\/jem.185.3.461","article-title":"Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells","volume":"185","author":"Rincon","year":"1997","journal-title":"J Exp Med"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.05.009_bib0420","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1128\/IAI.67.11.5747-5754.1999","article-title":"Interleukin-6 and interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine","volume":"67","author":"Leal","year":"1999","journal-title":"Infect Immun"},{"issue":"March (5615)","key":"10.1016\/j.vaccine.2011.05.009_bib0425","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1126\/science.1081902","article-title":"Pyogenic bacterial infections in humans with IRAK-4 deficiency","volume":"299","author":"Picard","year":"2003","journal-title":"Science"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2011.05.009_bib0430","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4049\/jimmunol.0803967","article-title":"Vaccine-induced CD8+ T cell-dependent suppression of airway hyperresponsiveness and inflammation","volume":"183","author":"Takeda","year":"2009","journal-title":"J Immunol"},{"issue":"August (36)","key":"10.1016\/j.vaccine.2011.05.009_bib0435","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.1016\/j.vaccine.2010.06.020","article-title":"Protection against pneumonic plague following oral immunization with a non-replicating vaccine","volume":"28","author":"Jones","year":"2010","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11007079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11007079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T23:55:06Z","timestamp":1686095706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11007079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":87,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0264410X11007079"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.05.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}